The S&P 500 Futures remain bullish after they kept their upward momentum yesterday, as both the S&P 500 and the Nasdaq 100 charged to fresh record closes. Investors were encouraged by an emergency authorization on Sunday by President Donald Trump to use convalescent plasma to treat Covid-19 patients.
Later today, the U.S. Commerce Department will release July new home sales (785,000 units expected). The Conference Board will report its Consumer Confidence Index for August (93.0 expected). The Federal Housing Finance Agency will post its house price index for June (+0.3% on month expected). SP Case Shiller will report its house price index for June (+0.1% on month expected). The Richmond Federal Reserve will post its Manufacturing Index for August (10 expected).
European indices remain in the green. The German Federal Statistical Office has reported final readings of 2Q GDP at -9.7% on quarter (vs -10.1% expected). Germany's August IFO Business Climate Index was released at 92.6 (vs 92.2 expected) and Expectations Index was published at 97.5 (vs 98.0 expected).
Asian indices closed in dispersed order as the Japanese Nikkei and the Australian ASX gained ground when the Hong Kong HSI and the Chinese CSI ended in the red. New Zealand Prime Minister Jacinda Ardern said Auckland's lockdown, which was re-imposed on August 12, will be extended by four days until August 30.
WTI Crude Oil futures are on the upside. 82% of oil output in the U.S. Gulf and more than a million barrels of refining capacity was shut down before the landing of Laura, which is forecast to become a hurricane. Later today, American Petroleum Institute (API) would release the change of U.S. oil stockpile data for August 21.
Gold consolidates before Jerome Powell's speech scheduled Thursday at Jackson Hole.
Gold fell 1.25 dollar (-0.06%) to 1927.63 dollars.
The US dollar edges lower as Asian currencies are benefiting from positive news on trade talks.
The dollar index fell 0.19pt to 93.109.
U.S. Equity Snapshot
Salesforce.com (CRM), Amgen (AMGN) and Honeywell International (HON) will replace Exxon Mobil (XOM), Pfizer (PFE) and Raytheon Technologies (RTX) in the Dow Jones Industrial Average Index effective prior to the opening of trading on August 31, according to the S&P Dow Jones Indices.
Source: TradingView, GAIN Capital
Apple (AAPL), the tech giant, plans to start to sell its products online in India next month, according to Bloomberg.
Medtronic (MDT), a developer and manufacturer of therapeutic medical devices, is gaining ground before hours after unveiling first quarter earnings that beat estimates.
Palo Alto Networks (PANW), a global cybersecurity leader, released fourth quarter adjusted EPS of 1.48 dollar, beating estimates, up from 1.47 dollar a year ago, on revenue of 950.4 million dollars, above forecasts, up from 805.8 million dollars a year earlier. The company also forecasts current quarter billings that were in line with current estimates, sending the shares down in extended trading.
Best Buy (BBY), the consumer electronics retailer, is losing ground before hours as the company didn't provide financial guidance as a result of ongoing uncertainty. Separately, Best Buy released second quarter adjusted EPS that beat estimates.
Tiffany (TIF): according to Reuters, LVMH could extend the deal deadline to buy the jeweler by three months. The deadline was intially set to expire on August 24.
Gap (GPS), a retailer of apparel, was upgraded to "buy" from "neutral" at Citi.
Nio (NIO), the Chinese electric-vehicle maker, was upgraded to "neutral" from "sell" at UBS.
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.